Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy

NARecruitingINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

March 11, 2022

Primary Completion Date

November 11, 2024

Study Completion Date

December 31, 2024

Conditions

Resistant Arterial Hypertension

Interventions

DIAGNOSTIC_TEST

Blood samples will be taken for pharmacokinetics and pharmacogenetics

To assess antihypertensive drugs concentration (lisinopril, valsartan, amlodipine, indapamide

Trial Locations (1)

RECRUITING

Ryzan State Medical University, Ryazan

All Listed Sponsors

lead

Ryazan State Medical University

OTHER